Skip to main content
. 2020 Aug 16;7(1):e000601. doi: 10.1136/bmjresp-2020-000601

Figure 2.

Figure 2

The use of digital technologies in CF. (A) Technologies used by the lay community (176 people) to help manage their treatment regimen versus what HCPs believe their patient’s to be using (137 people). (B) Views of how patients share their data that they collect from using digital technology versus what HCPs believe happen to these data. Respondents were able to select multiple responses. CF, cystic fibrosis; HCPs, healthcare professionals; pwCF, people with CF.